Patients with interval colorectal cancers have a similar risk for mortality as patients with clinically detected colorectal cancers, according to research published in Gastroenterology.

Henriette C. Jodal, MD, of the department of health management and health economics at the University of Oslo, in Norway, and colleagues wrote that their findings are contrary to the belief that cancers that develop rapidly between screenings are more lethal than clinically detected cancers.

Source: Interval colorectal cancer not more lethal than clinically detected disease